Evidence map›Paper›PMID 42205286›Full record

ArticleRSC advances2026

d-Leucine modified

Yujun Bao, Fujing Guan, Fengmei Shi, Su Wang, Liguo Wei, Pengfei Li, Zhanjiang Pei, Lishuang Zhao, Chuncheng Hao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yujun BaoDepartment of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital Harbin 150081 China.ORCID https://orcid.org/0000-0002-1951-5413
Fujing GuanPhysical and Chemical Inspection Department, Harbin Center for Disease Control and Prevention Harbin 150056 China.
Fengmei ShiKey Laboratory of Energy Utilization of Main Crop Stalk Resources, Heilongjiang Academy of Black Soil Conservation and Utilization Harbin 150086 China.
Su WangKey Laboratory of Energy Utilization of Main Crop Stalk Resources, Heilongjiang Academy of Black Soil Conservation and Utilization Harbin 150086 China.
Liguo WeiCollege of Environmental and Chemical Engineering, Heilongjiang University of Science and Technology Harbin 150025 China.ORCID https://orcid.org/0000-0001-5350-7874
Pengfei LiKey Laboratory of Energy Utilization of Main Crop Stalk Resources, Heilongjiang Academy of Black Soil Conservation and Utilization Harbin 150086 China.ORCID https://orcid.org/0000-0002-1075-1110
Zhanjiang PeiKey Laboratory of Energy Utilization of Main Crop Stalk Resources, Heilongjiang Academy of Black Soil Conservation and Utilization Harbin 150086 China.
Lishuang ZhaoCollege of Environmental and Chemical Engineering, Heilongjiang University of Science and Technology Harbin 150025 China.ORCID https://orcid.org/0000-0001-8640-1451
Chuncheng HaoDepartment of Head and Neck Radiation Oncology, Harbin Medical University Cancer Hospital Harbin 150081 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclic peptides show promise in cancer therapy but are hindered by low natural yields and poor metabolic stability. This study synthesized

Identifiers

PMID42205286
PMCPMC13202437

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.